Evommune, Inc. (EVMN) · INSIDERData sourcesSEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago
Public companyEvommune, Inc.
EVMNCIK 0002044725
Price$6.65
1 year-67.1%
Disclosed transactions38
Buys / sells2 / 3
Max Insider Score60
Connections with evidence9
EVMN · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 19 | PCPena Luis C.Director, President & CEO | EVMNEvommune, Inc. Grant or award | A | $7,827 1,115 sh | Sep 30, 2026 | Oct 15, 2026 |
| 24 | DSDrew Janice SuzannChief of Dev. Operations | EVMNEvommune, Inc. Open-market sale · 10b5-1 plan | SELL | $453K 20.0K sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 3 | DSDrew Janice SuzannChief of Dev. Operations | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | — 3,839 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 11 | DSDrew Janice SuzannChief of Dev. Operations | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | — 16.2K sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 3 | DSDrew Janice SuzannChief of Dev. Operations | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | $15K 3,839 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 0 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | — 1,488 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 0 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | $5,714 1,488 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 6 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 1,488 sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 7 | DSDrew Janice SuzannChief of Dev. Operations | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | $48K 16.2K sh | Jun 22, 2026 | Jun 24, 2026 traded Jun 22, 2026 | +2d | SEC Form 4 | |
| 10 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | $52K 13.5K sh | Jun 1, 2026 | Jun 3, 2026 traded Jun 1, 2026 | +2d | SEC Form 4 | |
| 11 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Option exercise · 10b5-1 plan | M | — 13.5K sh | Jun 1, 2026 | Jun 3, 2026 traded Jun 1, 2026 | +2d | SEC Form 4 | |
| 19 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Open-market sale · 10b5-1 plan | SELL | $379K 16.7K sh | Jun 1, 2026 | Jun 3, 2026 traded Jun 1, 2026 | +2d | SEC Form 4 | |
| 9 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Grant or award | A | — 69.3K sh | Apr 16, 2026 | Apr 17, 2026 traded Apr 16, 2026 | +1d | SEC Form 4 | |
| 9 | DSDrew Janice SuzannChief of Dev. Operations | EVMNEvommune, Inc. Grant or award | A | — 73.9K sh | Apr 16, 2026 | Apr 17, 2026 traded Apr 16, 2026 | +1d | SEC Form 4 | |
| 18 | VIVerduyn-van Weegen Felice IsabelDirector, 10% Owner | EVMNEvommune, Inc. Grant or award | A | $10.00M 358.7K sh | Feb 17, 2026 | Feb 18, 2026 traded Feb 17, 2026 | +1d | SEC Form 4 | |
| 19 | BEBauer EugeneDirector, Chief Medical Officer | EVMNEvommune, Inc. Grant or award | A | — 100.0K sh | Dec 8, 2025 | Dec 19, 2025 traded Dec 8, 2025 | +11d | SEC Form 4 | |
| 16 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Tax withholding | F | $134K 7,513 sh | Dec 9, 2025 | Dec 11, 2025 traded Dec 9, 2025 | +2d | SEC Form 4 | |
| 20 | MSMoss Gregory S.Chief Business & Legal Officer | EVMNEvommune, Inc. Tax withholding | F | $243K 13.6K sh | Dec 9, 2025 | Dec 11, 2025 traded Dec 9, 2025 | +2d | SEC Form 4 | |
| 20 | CKCarver KyleChief Financial Officer | EVMNEvommune, Inc. Tax withholding | F | $237K 13.3K sh | Dec 9, 2025 | Dec 11, 2025 traded Dec 9, 2025 | +2d | SEC Form 4 | |
| 16 | DSDrew Janice SuzannEVP, Operations | EVMNEvommune, Inc. Tax withholding | F | $91K 5,074 sh | Dec 9, 2025 | Dec 11, 2025 traded Dec 9, 2025 | +2d | SEC Form 4 | |
| 15 | LULSP 7 Cooperative UA10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 6.59M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | LULSP 7 Cooperative UA10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 5.09M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | DSDrew Janice SuzannEVP, Operations | EVMNEvommune, Inc. Derivative conversion | C | — 12.5K sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 60 | VIVerduyn-van Weegen Felice IsabelDirector, 10% Owner | EVMNEvommune, Inc. Open-market purchase | BUY | $25.00M 1.56M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 19 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Derivative conversion | C | — 3,175 sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Derivative conversion | C | — 25.0K sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | DSDrew Janice SuzannEVP, Operations | EVMNEvommune, Inc. Derivative conversion | C | — 1,587 sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | LULSP 7 Cooperative UA10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 15.49M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | VIVerduyn-van Weegen Felice IsabelDirector, 10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 3.37M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | VIVerduyn-van Weegen Felice IsabelDirector, 10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 6.59M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | VIVerduyn-van Weegen Felice IsabelDirector, 10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 5.09M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 60 | LULSP 7 Cooperative UA10% Owner | EVMNEvommune, Inc. Open-market purchase | BUY | $25.00M 1.56M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | LULSP 7 Cooperative UA10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 3.37M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 15 | VIVerduyn-van Weegen Felice IsabelDirector, 10% Owner | EVMNEvommune, Inc. Derivative conversion | C | — 15.49M sh | Nov 7, 2025 | Nov 12, 2025 traded Nov 7, 2025 | +5d | SEC Form 4 | |
| 9 | DSDrew Janice SuzannEVP, Operations | EVMNEvommune, Inc. Grant or award | A | — 231.3K sh | Nov 5, 2025 | Nov 7, 2025 traded Nov 5, 2025 | +2d | SEC Form 4 | |
| 9 | PPPatel Jeegar PravinkumarChief Scientific Officer | EVMNEvommune, Inc. Grant or award | A | — 179.6K sh | Nov 5, 2025 | Nov 7, 2025 traded Nov 5, 2025 | +2d | SEC Form 4 | |
| 9 | MSMoss Gregory S.Chief Business & Legal Officer | EVMNEvommune, Inc. Grant or award | A | — 293.5K sh | Nov 5, 2025 | Nov 7, 2025 traded Nov 5, 2025 | +2d | SEC Form 4 | |
| 9 | CKCarver KyleChief Financial Officer | EVMNEvommune, Inc. Grant or award | A | — 279.4K sh | Nov 5, 2025 | Nov 7, 2025 traded Nov 5, 2025 | +2d | SEC Form 4 | |
Director, 10% Owner · Nov 12, 2025